Natalie A Clark1, Sunni L Mumford, James H Segars. 1. aDepartment of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan bEpidemiology Branch, Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development cProgram in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA.
Abstract
PURPOSE OF REVIEW: Magnetic-resonance-guided focused ultrasound surgery (MRgFUS) is a minimally invasive technique for the treatment of uterine fibroids. The purpose of this review is to highlight the impact of MRgFUS on fertility and reproductive outcomes. RECENT FINDINGS: The role of MRgFUS in the treatment of fibroids has been evolving since its introduction in 2004. Several new devices and techniques including location-specific treatment, volumetric therapy, and vessel-targeted therapy have been introduced over the last few years. Several case series report uncomplicated pregnancy following MRgFUS; however, results of the ongoing studies will further elucidate the utility of MRgFUS in patients planning future fertility. A systematic review of the literature was completed and studies that reported quality of life at baseline and after 6 months were included in a meta-analysis. SUMMARY: MRgFUS represents a minimally invasive treatment for uterine fibroids that is able to improve the quality of life and fibroid size with durability. It is possible that MRgFUS could be the treatment of choice for patients desiring future fertility; however, further investigation is needed.
PURPOSE OF REVIEW: Magnetic-resonance-guided focused ultrasound surgery (MRgFUS) is a minimally invasive technique for the treatment of uterine fibroids. The purpose of this review is to highlight the impact of MRgFUS on fertility and reproductive outcomes. RECENT FINDINGS: The role of MRgFUS in the treatment of fibroids has been evolving since its introduction in 2004. Several new devices and techniques including location-specific treatment, volumetric therapy, and vessel-targeted therapy have been introduced over the last few years. Several case series report uncomplicated pregnancy following MRgFUS; however, results of the ongoing studies will further elucidate the utility of MRgFUS in patients planning future fertility. A systematic review of the literature was completed and studies that reported quality of life at baseline and after 6 months were included in a meta-analysis. SUMMARY: MRgFUS represents a minimally invasive treatment for uterine fibroids that is able to improve the quality of life and fibroid size with durability. It is possible that MRgFUS could be the treatment of choice for patients desiring future fertility; however, further investigation is needed.
Authors: Aradhana M Venkatesan; Ari Partanen; Tajana Klepac Pulanic; Matthew R Dreher; John Fischer; Robert K Zurawin; Raja Muthupillai; Sham Sokka; Heikki J Nieminen; Ninet Sinaii; Maria Merino; Bradford J Wood; Pamela Stratton Journal: J Vasc Interv Radiol Date: 2012-06 Impact factor: 3.464
Authors: Sang-Wook Yoon; Sun Hee Cha; Young Geon Ji; Hyun Cheol Kim; Mee Hwa Lee; Jin Ho Cho Journal: Eur J Obstet Gynecol Reprod Biol Date: 2013-03-22 Impact factor: 2.435
Authors: Fiona M Fennessy; Clare M Tempany; Nathan J McDannold; Minna J So; Gina Hesley; Bobbie Gostout; Hyun S Kim; George A Holland; Dennis A Sarti; Kullervo Hynynen; Ferenc A Jolesz; Elizabeth A Stewart Journal: Radiology Date: 2007-04-19 Impact factor: 11.105
Authors: Esther V A Bouwsma; Krzysztof R Gorny; Gina K Hesley; Jani R Jensen; Lisa G Peterson; Elizabeth A Stewart Journal: Fertil Steril Date: 2011-05-13 Impact factor: 7.329
Authors: Fabiana Ferrari; Francesco Arrigoni; Anna Miccoli; Sara Mascaretti; Eva Fascetti; Giulio Mascaretti; Antonio Barile; Carlo Masciocchi Journal: Radiol Med Date: 2015-09-09 Impact factor: 3.469
Authors: Carlo Masciocchi; Francesco Arrigoni; Fabiana Ferrari; Aldo Victor Giordano; Sonia Iafrate; Ilaria Capretti; Ester Cannizzaro; Alfonso Reginelli; Anna Maria Ierardi; Chiara Floridi; Alessio Salvatore Angileri; Luca Brunese; Antonio Barile Journal: Med Oncol Date: 2017-02-24 Impact factor: 3.064
Authors: Aymara Mas; Marta Tarazona; Joana Dasí Carrasco; Gloria Estaca; Ignacio Cristóbal; Javier Monleón Journal: Int J Womens Health Date: 2017-09-05